Atea Pharmaceuticals Inc (AVIR)
3.73
+0.06
(+1.63%)
USD |
NASDAQ |
Apr 23, 16:00
3.73
0.00 (0.00%)
After-Hours: 20:00
Atea Pharmaceuticals Total Assets (Quarterly): 594.97M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 594.97M |
| September 30, 2023 | 608.08M |
| June 30, 2023 | 626.03M |
| March 31, 2023 | 638.13M |
| December 31, 2022 | 666.71M |
| September 30, 2022 | 686.58M |
| June 30, 2022 | 694.34M |
| March 31, 2022 | 717.19M |
| Date | Value |
|---|---|
| December 31, 2021 | 772.89M |
| September 30, 2021 | 843.50M |
| June 30, 2021 | 871.54M |
| March 31, 2021 | 840.65M |
| December 31, 2020 | 863.63M |
| September 30, 2020 | 110.11M |
| June 30, 2020 | 119.74M |
| December 31, 2019 | 22.07M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
22.07M
Minimum
Dec 2019
871.54M
Maximum
Jun 2021
604.76M
Average
676.64M
Median
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp | 28.71M |
| AIM ImmunoTech Inc | 19.38M |
| IGC Pharma Inc | 11.26M |
| NovaBay Pharmaceuticals Inc | 9.034M |
| Protalix BioTherapeutics Inc | 84.43M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 39.78M |
| Shareholders Equity (Quarterly) | 555.19M |